Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydroxydione is a synthetic neuroactive steroid that was previously used as a general anesthetic. It acts primarily as a positive allosteric modulator of the GABA_A receptor, enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) in the central nervous system. Hydroxydione was introduced in the early 1950s under the brand name Viadril for intravenous anesthesia but was later withdrawn from clinical use due to reports of thrombophlebitis and other adverse reactions. It is structurally related to endogenous neurosteroids and represents one of the earliest examples of steroid-based anesthetics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydroxydione.